Literature DB >> 30191306

Clinically significant radiographic parameter for thoracic myelopathy caused by ossification of the ligamentum flavum.

Byung-Jou Lee1, Jin Hoon Park2,3, Sang-Ryong Jeon1, Seung-Chul Rhim1, Sung Woo Roh4,5.   

Abstract

PURPOSE: To investigate radiographic parameters to improve the accuracy of radiologic diagnosis for ossification of ligamentum flavum (OLF)-induced thoracic myelopathy and thereby establish a useful diagnostic method for identifying the responsible segment.
METHODS: We classified 101 patients who underwent surgical treatment for OLF-induced thoracic myelopathy as the myelopathy group and 102 patients who had incidental OLF and were hospitalized with compression fracture as the non-myelopathy group between January 2009 and December 2016. We measured the thickness of OLF (TOLF), cross-sectional area of OLF (AOLF), anteroposterior canal diameter, and the ratio of each of these parameters.
RESULTS: Most OLF cases with lateral-type axial morphology were in the non-myelopathy group and most with fused and tuberous type in the myelopathy group. Most grade-I and grade-II cases were also in the non-myelopathy group, whereas grade-IV cases were mostly observed in the myelopathy group. The AOLF ratio was found to be the best radiologic parameter. The optimal cutoff point of the AOLF ratio was 33.00%, with 87.1% sensitivity and 87.3% specificity. The AOLF ratio was significantly correlated with preoperative neurological status.
CONCLUSIONS: An AOLF ratio greater than 33% is the most accurate diagnostic indicator of OLF-induced thoracic myelopathy. In cases of multiple-segment OLF, confirmation of cord signal change on MRI and an AOLF measurement will help determine the responsible segment. AOLF measurement will also improve the accuracy of diagnosis of OLF-induced thoracic myelopathy in cases of grade III or extended-type axial morphology. These slides can be retrieved under Electronic Supplementary Material.

Entities:  

Keywords:  Area of ligamentum flavum; Optimal cutoff point; Ossification of ligamentum flavum; Thickness of ligamentum flavum; Thoracic myelopathy

Year:  2018        PMID: 30191306     DOI: 10.1007/s00586-018-5750-6

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  19 in total

1.  Ossification of the ligamentum flavum of the thoracic spine in the Korean population.

Authors:  Kyung-Chung Kang; Chong-Suh Lee; Seung-Kee Shin; Se-Jun Park; Chul-Hee Chung; Sung-Soo Chung
Journal:  J Neurosurg Spine       Date:  2011-01-28

2.  MRI of ossification of ligamentum flavum.

Authors:  H Sugimura; Y Kakitsubata; Y Suzuki; S Kakitsubata; S Tamura; O Uwada; T Kodama; T Yano; K Watanabe
Journal:  J Comput Assist Tomogr       Date:  1992 Jan-Feb       Impact factor: 1.826

3.  Thoracic myelopathy due to ossification of ligamentum flavum: a retrospective analysis of predictors of surgical outcome and factors affecting preoperative neurological status.

Authors:  Amish V Sanghvi; Harvinder Singh Chhabra; Amrithlal A Mascarenhas; Vivek K Mittal; Gururaj M Sangondimath
Journal:  Eur Spine J       Date:  2010-05-15       Impact factor: 3.134

4.  Thoracic myelopathy caused by ossification of the ligamentum flavum: clinical features and surgical results in the Japanese population.

Authors:  Toshimi Aizawa; Tetsuro Sato; Hirotoshi Sasaki; Takashi Kusakabe; Naoki Morozumi; Shoichi Kokubun
Journal:  J Neurosurg Spine       Date:  2006-12

5.  The thickness of the ligamentum flavum in relation to age and gender.

Authors:  Alp Alper Safak; Merih Is; Ozdemir Sevinc; Cagatay Barut; Nesrin Eryoruk; Besir Erdogmus; Murat Dosoglu
Journal:  Clin Anat       Date:  2010-01       Impact factor: 2.414

6.  Epidemiological survey of ossification of the ligamentum flavum in thoracic spine: CT imaging observation of 993 cases.

Authors:  Ning Lang; Hui Shu Yuan; Hong Lei Wang; Jing Liao; Man Li; Fu Xin Guo; Shan Shi; Zhong Qiang Chen
Journal:  Eur Spine J       Date:  2012-09-15       Impact factor: 3.134

Review 7.  A review of factors predictive of surgical outcome for ossification of the ligamentum flavum of the thoracic spine.

Authors:  Joji Inamasu; Bernard H Guiot
Journal:  J Neurosurg Spine       Date:  2006-08

8.  Pathomechanism of ligamentum flavum hypertrophy: a multidisciplinary investigation based on clinical, biomechanical, histologic, and biologic assessments.

Authors:  Koichi Sairyo; Ashok Biyani; Vijay Goel; Douglas Leaman; Robert Booth; Jean Thomas; Daniel Gehling; Lakshmi Vishnubhotla; Rebecca Long; Nabil Ebraheim
Journal:  Spine (Phila Pa 1976)       Date:  2005-12-01       Impact factor: 3.468

9.  Thoracic myelopathy caused by ossification of the yellow ligament in patients with posterior instrumented lumbar fusion.

Authors:  Kee-Yong Ha; Jun-Yeong Seo; Il-Nam Son; Young-Hoon Kim; Ki-Won Kim
Journal:  Eur Spine J       Date:  2012-06-30       Impact factor: 3.134

10.  Spinal cord evoked potentials in thoracic myelopathy with multisegmental vertebral involvement.

Authors:  H Baba; K Tomita; N Kawahara; Y Kikuchi; S Imura
Journal:  Spine (Phila Pa 1976)       Date:  1992-11       Impact factor: 3.468

View more
  7 in total

1.  Clinical Characteristics of Patients with Ossification of the Posterior Longitudinal Ligament and a High OP Index: A Multicenter Cross-Sectional Study (JOSL Study).

Authors:  Takashi Hirai; Toshitaka Yoshii; Jun Hashimoto; Shuta Ushio; Kanji Mori; Satoshi Maki; Keiichi Katsumi; Narihito Nagoshi; Kazuhiro Takeuchi; Takeo Furuya; Kei Watanabe; Norihiro Nishida; Soraya Nishimura; Kota Watanabe; Takashi Kaito; Satoshi Kato; Katsuya Nagashima; Masao Koda; Hiroaki Nakashima; Shiro Imagama; Kazuma Murata; Yuji Matsuoka; Kanichiro Wada; Atsushi Kimura; Tetsuro Ohba; Hiroyuki Katoh; Masahiko Watanabe; Yukihiro Matsuyama; Hiroshi Ozawa; Hirotaka Haro; Katsushi Takeshita; Morio Matsumoto; Masaya Nakamura; Satoru Egawa; Yu Matsukura; Hiroyuki Inose; Atsushi Okawa; Masashi Yamazaki; Yoshiharu Kawaguchi
Journal:  J Clin Med       Date:  2022-06-27       Impact factor: 4.964

2.  Comparing Thoracic Extensive Laminoplasty (TELP) and Laminectomy in Treating Severe Thoracic Ligamentum Flavum Ossification: A Proposed Novel Technique and Case-Control Study.

Authors:  Jun Ma; Zhengyu Lu; Xin Zhou; Jia Yin; Enjie Xu; Heng Jiang; Xiao Ma; Yichen Meng; Zhilin Li; Rui Gao; Tao Lin; Xuhui Zhou
Journal:  Biomed Res Int       Date:  2021-04-20       Impact factor: 3.411

3.  Dissatisfaction Risk Factors of Patients after Laminectomy for Thoracic Ossification of Ligamentum Flavum: A Retrospective Cohort Study of Different Follow-Up Periods.

Authors:  Zhiwei Wang; Sidong Yang; Xianda Gao; Zheng Wang; Wenyuan Ding; Dalong Yang
Journal:  Pain Res Manag       Date:  2021-12-20       Impact factor: 3.037

4.  The clinical value of three-dimensional measurement in the diagnosis of thoracic myelopathy caused by ossification of the ligamentum flavum.

Authors:  Chen Yan; Hao-Yuan Tan; Cheng-Long Ji; Xue-Wei Yu; Huai-Cheng Jia; Fu-Dong Li; Gui-Cheng Jiang; Wei-Shi Li; Fei-Fei Zhou; Zhen Ye; Jing-Chuan Sun; Jian-Gang Shi
Journal:  Quant Imaging Med Surg       Date:  2021-05

Review 5.  Thoracic ligamentum flavum ossification: a rare cause of spinal cord injury without tomographic evidence of trauma in a Caucasian patient. Case report and literature review.

Authors:  Guillermo Alejandro Ricciardi; Ignacio Gabriel Garfinkel; Gabriel Genaro Carrioli; Daniel Oscar Ricciardi
Journal:  Spinal Cord Ser Cases       Date:  2021-07-09

6.  Bilateral translaminar osseous-channel assisted percutaneous full-endoscopic ligamentectomy decompression for thoracic myelopathy due to ossification of the ligamentum flavum: a technical note.

Authors:  Zhijun Xin; Weijun Kong; Qian Du; Wenbo Liao
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2020-11-15       Impact factor: 1.195

7.  Thoracic full-endoscopic unilateral laminotomy with bilateral decompression for treating ossification of the ligamentum flavum with myelopathy.

Authors:  Yong-Peng Lin; Rui Lin; Song Chen; Si-Yuan Rao; Shuai Zhao; Tao Wen; Hong-Shen Wang; Wei-Xiong Hu; Bing-Xin Liu; Xin-Yi Li; Yong-Jin Li; Bo-Lai Chen
Journal:  Ann Transl Med       Date:  2021-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.